Augmedix to Report First Quarter 2022 Financial Results on May 9, 2022

Rhea-AI Summary

Augmedix, Inc. (Nasdaq: AUGX) will announce its financial results for Q1 2022 on May 9, 2022, after market close. The company provides automated medical documentation services aimed at easing the administrative workload of healthcare professionals, enhancing patient care. Interested parties can join the earnings call at 1:30 p.m. PT and access the webcast on Augmedix's website. The company offers a platform utilizing automatic speech recognition and natural language processing to generate structured medical notes from physician-patient conversations.

Positive

• Augmedix's innovative platform improves efficiency in medical documentation, potentially leading to higher adoption rates.
• Earnings call scheduled to provide investors with insights into company performance and future guidance.

Negative

• None.

SAN FRANCISCO, April 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the first quarter of 2022 on Monday, May 9, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Conference Call & Webcast Details
The conference call can be accessed by dialing + 1-877-300-8521 for U.S. participants or +1 (412) 317-6026 for international participants and referencing conference ID # 10166440. Interested parties may access a live and archived webcast of the event on the “Events” section of the Company’s website at: https://ir.augmedix.com/news-events.

About Augmedix

Augmedix, Inc. (Nasdaq: AUGX) provides automated medical documentation and data services to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments, and telemedicine nationwide. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and performs a suite of related data services. These services relieve physicians of administrative burdens to enable more time for patient care. Augmedix’s proprietary platform uses automatic speech recognition, natural language processing and clinical datasets to capture the ambient visit conversation and generate a structured medical note. The structured medical note data is then used to deliver additional data services. Quality is assured by trained medical documentation specialists. To learn more about Augmedix, visit augmedix.com.

Investors:
Caroline Paul
Gilmartin Group
investors@augmedix.com

Media:
Kaila Grafeman
Augmedix
pr@augmedix.com

FAQ

When will Augmedix report its financial results for Q1 2022?

Augmedix will report its financial results for Q1 2022 on May 9, 2022, after market close.

What time is the Augmedix earnings call for Q1 2022?

The Augmedix earnings call for Q1 2022 is scheduled for 1:30 p.m. Pacific Time.

How can I access the Augmedix earnings call?

You can access the Augmedix earnings call by dialing +1-877-300-8521 for U.S. participants or +1 (412) 317-6026 for international participants, referencing conference ID # 10166440.

What services does Augmedix provide?

Augmedix provides automated medical documentation and data services, helping healthcare professionals generate structured medical notes from patient interactions.